Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: Crisugabalin for Radiotherapy-Related Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for crisugabalin as treatment for radiotherapy-related neuropathic pain; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crisugabalin (crisugabalin)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Neuropathic Pain | Phase 2 | Status: RECRUITING